Skip to main content
. 2020 Sep 14;20:282. doi: 10.1186/s12866-020-01966-6

Table 1.

Parallel detection data from both the CRISPR-Cas12a and commercial qPCR assays in clinical samples

Sample types Nucleic acid detection assays
CRISPR-Cas12a assay Commercial qPCR
Blood 19/67a 18/67
Oral fluid 14/18 13/18
Spleen 11/16 11/16

a number of positive/total samples